Meulman, J.; Davanço, M.G.; Vianna, D.R.B.; da Silva, T.M.; Costa, F.; Pacheco, F.B.C.; de Oliveira, M.E.; Vespasiano, C.F.P.
Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions. Pharmaceutics 2023, 15, 2569.
https://doi.org/10.3390/pharmaceutics15112569
AMA Style
Meulman J, Davanço MG, Vianna DRB, da Silva TM, Costa F, Pacheco FBC, de Oliveira ME, Vespasiano CFP.
Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions. Pharmaceutics. 2023; 15(11):2569.
https://doi.org/10.3390/pharmaceutics15112569
Chicago/Turabian Style
Meulman, Jessica, Marcelo Gomes Davanço, Débora Renz Barreto Vianna, Thalita Martins da Silva, Fernando Costa, Fernando Bastos Canton Pacheco, Milla Emke de Oliveira, and Celso Francisco Pimentel Vespasiano.
2023. "Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions" Pharmaceutics 15, no. 11: 2569.
https://doi.org/10.3390/pharmaceutics15112569
APA Style
Meulman, J., Davanço, M. G., Vianna, D. R. B., da Silva, T. M., Costa, F., Pacheco, F. B. C., de Oliveira, M. E., & Vespasiano, C. F. P.
(2023). Etoricoxib Coated Tablets: Bioequivalence Assessment between Two Formulations Administered under Fasting Conditions. Pharmaceutics, 15(11), 2569.
https://doi.org/10.3390/pharmaceutics15112569
